Korify Capital focuses on backing breakthrough technologies in longevity and mental health, aiming to invest in companies redefining these sectors. They target companies with strong traction and proof of concept, positioned to be future leaders. Their investment strategy centers on three key areas: distributed development companies, enabling technologies, and domain-specific platforms. Distributed development companies (DisCos) mitigate the risk of failed clinical trials by providing infrastructure for multiple uncorrelated development programs, offering a faster-maturing and capital-efficient investment. Enabling technologies encompass innovations improving processes or aspects of drug development, from brain-computer interfaces to advances in manufacturing and AI. Domain-specific platforms possess unique capabilities to identify novel targets and compounds around a thematic focus, typically focusing on new therapeutic modalities or transforming drug discovery processes. The firm believes biotechnology will be one of the most impactful sectors and is dedicated to investing in visionary companies with the potential to cure and prevent diseases, allowing individuals to live longer and healthier lives.
Preferred startup development maturity for initial funding deployment.
Longevity, Mental Health, Regenerative Medicine, Digital Wellbeing, Biotech, Female Health
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...